Phathom Pharmaceuticals, Inc. PHAT Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s total operating expenses?
- Phathom Pharmaceuticals, Inc. (PHAT) reported total operating expenses of $61.78M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s total operating expenses changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s total operating expenses decreased by 40.4% year-over-year, from $103.66M to $61.78M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s total operating expenses?
- Over 4 years (2021 to 2025), Phathom Pharmaceuticals, Inc.'s total operating expenses has grown at a 23.3% compound annual growth rate (CAGR), from $135.08M to $312.5M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.